Companies House true 2024-02-29 2025-02-28 false 14663026 uk-bus:Director1 2024-02-29 2025-02-28 14663026 uk-bus:Director2 2024-02-29 2025-02-28 14663026 2024-02-29 2025-02-28 14663026 2025-02-28 14663026 uk-bus:EntityHasNeverTraded 2024-02-29 2025-02-28 14663026 uk-bus:FRS102 2024-02-29 2025-02-28 14663026 uk-bus:FullAccounts 2024-02-29 2025-02-28 14663026 uk-bus:AuditExempt-NoAccountantsReport 2024-02-29 2025-02-28 14663026 2024-02-28 14663026 uk-bus:OrdinaryShareClass1 2024-02-29 2025-02-28 14663026 uk-bus:OrdinaryShareClass2 2024-02-29 2025-02-28 14663026 uk-bus:OrdinaryShareClass3 2024-02-29 2025-02-28 14663026 uk-bus:PreferenceShareClass1 2024-02-29 2025-02-28 14663026 uk-bus:PreferenceShareClass2 2024-02-29 2025-02-28 14663026 uk-bus:PreferenceShareClass3 2024-02-29 2025-02-28 14663026 uk-core:ShareCapitalPreferenceShares 2025-02-28 14663026 uk-core:ShareCapitalPreferenceShares 2024-02-28 iso4217:GBP iso4217:GBP xbrli:shares xbrli:shares

Registered Number 14663026

APLEXIA PHARMA LIMITED

Dormant Accounts

28 February 2025

## APLEXIA PHARMA LIMITED Registered Number 14663026

## Balance Sheet as at 28 February 2025

|  | 2025 | 2024
--- | --- | --- | ---
|  | £ | £
Current assets
Cash at bank and in hand |  | 2 | 2
Net assets |  | 2 | 2
Issued share capital
2 Ordinary Shares of £ 1 each |  | 2 | 2
Total Shareholder funds |  | 2 | 2

### STATEMENTS

1. For the year ending 28 February 2025 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 9 October 2025

And signed on their behalf by:
Dhananjay Kumar Mishra, Director